NCT01188980

Brief Summary

The purpose of this study is to determine if early Barrett's specialized intestinal metaplasia can be detected by measuring early increased blood supply of the esophageal tissue, with 4 Dimensional Elastic Light-Scattering Fingerprinting, (4D-ELF) technology in real time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 26, 2010

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

April 22, 2016

Status Verified

April 1, 2016

Enrollment Period

2.8 years

First QC Date

August 24, 2010

Last Update Submit

April 21, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • determine if early increase blood supply (EIBS)can predict presence of Dysplasia

    To determine if early increase blood supply (EIBS), as measured in Barrett's glandular mucosa segment, can predict the presence of Dysplasia in patients with known diagnosis of Barrett's esophagus (BE).

    10 minutes during standard upper endoscopy

Secondary Outcomes (1)

  • determine if EIBS can predict presence of BE in patients undergoing upper endoscopy

    10 minutes

Study Arms (3)

NoBE (control)

BE without dysplasia

BE with dysplasia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Control Population: Patients with no Barrett's metaplasia scheduled for upper endoscopy at Mayo Clinic Jacksonville. Experimental Population: Patients with biopsy-proven Barrett's esophagus and previously scheduled for upper endoscopy at Mayo Clinic Jacksonville.

You may qualify if:

  • age 18 years or older,
  • informed written consent,
  • patient scheduled for previously planned upper endoscopy

You may not qualify if:

  • liver disease;
  • gastric antral vascular ectasia (GAVE);any known non-esophageal aerodigestive malignancy;
  • severe cardiopulmonary disease precluding endoscopy; presence of conditions not allowing biopsy (e.g. coagulation disorder);
  • known familial polyposis syndrome (FAP, HNPCC, Juvenile polyposis, etc.);
  • known pregnancy or sexually active females of childbearing age who are not practicing an accepted form of birth control.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Jacksonville, Florida, 32224, United States

Location

MeSH Terms

Conditions

Barrett Esophagus

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine, Mayo College of Medicine, Director of Endoscopy, Mayo Clinic Florida

Study Record Dates

First Submitted

August 24, 2010

First Posted

August 26, 2010

Study Start

June 1, 2010

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

April 22, 2016

Record last verified: 2016-04

Locations